J2H Biotech Co., Ltd.

J2H Biotech Pharmaceutical Business Division was established in November 2020 and received GMP approval from the Korea Ministry of Food and Drug Safety in June 2022, focusing on manufacturing and quality control of high-value APIs. Source (opens in a new tab)

Headquarters

KR

Provider types

CDMO, API manufacturer